These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 11364452

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. New drug approved to treat HIV.
    Treat Rev; 1997 Apr; (No 24):5. PubMed ID: 11364284
    [Abstract] [Full Text] [Related]

  • 3. Nelfinavir (Viracept) approved: fourth protease inhibitor available.
    James JS.
    AIDS Treat News; 1997 Mar 21; (No 267):1-2. PubMed ID: 11364249
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Nelfinavir: fourth protease inhibitor approved.
    Crit Path AIDS Proj; 1997 Mar 21; (No 32):31-2. PubMed ID: 11364442
    [Abstract] [Full Text] [Related]

  • 6. FDA approves nelfinavir. Food and Drug Administration.
    GMHC Treat Issues; 1997 Mar 21; 11(3):8. PubMed ID: 11364277
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Nelfinavir at six months.
    PI Perspect; 1997 Mar 21; (No 21):11-2. PubMed ID: 11364207
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Fourth protease inhibitor hits the market.
    AIDS Alert; 1997 May 21; 12(5):59-60. PubMed ID: 11364224
    [Abstract] [Full Text] [Related]

  • 12. Newly approved PI provides treatment options.
    AIDS Alert; 1997 Jun 21; 12(6):68-9. PubMed ID: 11364360
    [Abstract] [Full Text] [Related]

  • 13. Nelfinavir is number 4 -- but should it bat cleanup, or lead off?
    Mascolini M.
    J Int Assoc Physicians AIDS Care; 1997 Jun 21; 3(6):17-21. PubMed ID: 11364427
    [Abstract] [Full Text] [Related]

  • 14. Pediatric treatments.
    AIDS Policy Law; 1997 Apr 04; 12(6):12. PubMed ID: 11364179
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients.
    Idoko JA, Akinsete L, Abalaka AD, Keshinro LB, Dutse L, Onyenekwe B, Lhekwaba A, Njoku OS, Kehinde MO, Wambebe CO.
    West Afr J Med; 2002 Apr 04; 21(2):83-6. PubMed ID: 12403023
    [Abstract] [Full Text] [Related]

  • 17. New formulation of saquinavir (Fortovase) is more effective.
    Tam CW.
    Fac Notes (New Orleans La); 1998 Apr 04; 10(2):11. PubMed ID: 11365126
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Protease inhibitor trials moving to next phase.
    AIDS Alert; 1995 Aug 04; 10(8):100-1. PubMed ID: 11362675
    [Abstract] [Full Text] [Related]

  • 20. Agouron protease inhibitor.
    AIDS Treat News; 1995 Sep 29; (no 231):5. PubMed ID: 11362869
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.